Gyermekkori daganatok: vizsgálatok itt: Németország
144 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- Korai 1. fázisNot yet taking people in NémetországLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Where
- Heidelberg
- Életkor
- 1 év to 21 év
- People
- 15 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06333899 - No phaseTaking peopleSPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
- Where
- Berlin, Dresden, Greifswald, Jena, Leer
- Életkor
- 12 év and over
- People
- 4975 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT02834884 - 2/3. fázisTaking peopleSIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
- Where
- Aachen, Augsburg, Berlin, Bielefeld, Bonn, Bremen, Brunswick, Dortmund, Dresden, Duisburg, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Greifswald, Halle Saale, Hamburg, Hanover, Heidelberg, Heilbronn, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Krefeld, Leipzig, Luebeck, Magdeburg, Mainz, Mannheim, Minden, Muenster, Munich, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Wuerzburg
- Életkor
- Up to 64 év
- People
- 894 worldwide
- Run by
- Centre Leon Berard
See details and how to joinNCT02265770 · EU 2024-512222-28-00 - 2. fázisNot yet taking people in NémetországStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Where
- Heidelberg
- Életkor
- 12 hónap to 39 év
- People
- 120 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05843253 - 1/2. fázisFut, nem toborozA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Dresden, Heidelberg
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - 2/3. fázisTaking peopleCardiorespiratory Fitness in Children and Adolescents After Cancer Treatment.
- Where
- Krefeld
- Életkor
- 7 év to 23 év
- People
- 56
- Run by
- Universität Duisburg-Essen
See details and how to joinNCT04765020 - 3. fázisTaking peopleStudy on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
- Where
- Aachen, Augsburg, Berlin, Bremen, Dortmund, Dresden, Düsseldorf, Erlangen, Essen, Frankfurt, Freiburg im Breisgau, Giessen, Hamburg, Hannover, Heidelberg, Homburg, Kiel, Leipzig, Mainz, Münster, Stuttgart, Tübingen, Ulm
- Életkor
- Up to 64 év
- People
- 87 worldwide
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 - 1/2. fázisTaking peopleA phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
- Where
- Berlin, Essen, Frankfurt Am Main, Hamburg, Muenster
- Életkor
- Up to 64 év
- People
- 72 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504880-18-00 - No phaseTaking peopleAdrenal Tumors - Pathogenesis and Therapy
- Where
- Würzburg
- Életkor
- Up to 100 év
- People
- 500
- Run by
- University of Wuerzburg
See details and how to joinNCT00669266 - 3. fázisTaking peopleInternational Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
- Where
- Aachen, Augsburg, Berlin, Bielefeld, Bonn, Bremen, Brunswick, Cologne, Cottbus, Datteln, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Greifswald, Halle (Saale), Hamburg, Hanover, Heidelberg, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Krefeld, Leipzig, Luebeck, Magdeburg, Mainz, Mannheim, Minden, Muenster, Munich, Nuernberg, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Wuerzburg
- Életkor
- Up to 18 év
- People
- 683 worldwide
- Run by
- University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00 - 2. fázisFut, nem toborozSafety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms
- Where
- Münster
- Életkor
- 6 hónap to 17 év
- People
- 31 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT06508931 · EU 2023-506348-17-00 - No phaseTaking peopleStudy for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood
- Where
- Freiburg im Breisgau
- Életkor
- Up to 17 év
- People
- 260
- Run by
- University Hospital Freiburg
See details and how to joinNCT00662090 - No phaseTaking peopleDiagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes
- Where
- Tübingen
- People
- 12 000
- Run by
- University Hospital Tuebingen
See details and how to joinNCT04731857 - 1/2. fázisTaking peoplePersonalized Vaccination in Fusion+ Sarcoma Patients (PerVision)
- Where
- Berlin, Dresden, Essen, Frankfurt Am Main, Freiburg, Munich, Tuebingen
- Életkor
- 2 év to 40 év
- People
- 30
- Run by
- University Hospital Tuebingen
See details and how to joinNCT06094101 · EU 2024-511337-35-00 - No phaseTaking peoplePhysical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma
- Where
- Hamburg
- People
- 40
- Run by
- Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT07564570 - No phaseTaking peopleMPN Childhood Registry
- Where
- Erlangen
- Életkor
- 0 év to 17 év
- People
- 500
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT07410247 - 2. fázisNot yet taking people in NémetországTovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
- Where
- Heidelberg
- Életkor
- 1 év to 39 év
- People
- 57 worldwide
- Run by
- Sabine Mueller, MD, PhD
See details and how to joinNCT05465174 · EU 2024-511510-20-00 - 3. fázisTaking peopleONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
- Where
- Augsburg, Berlin, Bonn, Cologne, Essen, Frankfurt Am Main, Heidelberg, Mannheim, Regensburg, Tuebingen
- People
- 510 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00 - 2/3. fázisNot yet taking people in NémetországA Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Where
- Berlin, Hamburg, Heidelberg
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06581406 · EU 2023-508784-68-00 - 2. fázisTaking peopleInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Aachen, Augsburg, Berlin, Bielefeld, Bonn, Bremen, Brunswick, Cologne, Cottbus, Datteln, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Greifswald, Halle Saale, Hamburg, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Leipzig, Magdeburg, Mainz, Muenster, Munich, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Wuerzburg
- Életkor
- Up to 17 év
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00 - 2. fázisTaking peopleA study to determine how safe MB-CART2019.1 is and how well it works in children and adolescents with B cell neoplasms
- Where
- Muenster
- Életkor
- Up to 17 év
- People
- 12 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT06508951 - 1. fázisTaking peopleLong-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
- Where
- Berlin, Dresden, Marburg, Munich, Ulm
- Életkor
- 18 év and over
- People
- 178
- Run by
- AvenCell Therapeutics, Inc.
See details and how to joinNCT07474051 · EU 2025-521717-67-00 - No phaseTaking peoplePrimary Tumor Research and Outcomes Network
- Where
- Dresden
- People
- 1350 worldwide
- Run by
- AO Innovation Translation Center
See details and how to joinNCT02790983 - No phaseNot yet taking people in NémetországOutcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
- Where
- Essen
- People
- 212 worldwide
- Run by
- Mayo Clinic
See details and how to joinNCT06689956 - No phaseNot yet taking people in NémetországDigital Solutions for bEtter cAre
- Where
- Homburg
- Életkor
- 12 év and over
- People
- 200 worldwide
- Run by
- European Institute of Oncology
See details and how to joinNCT07416513